These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2568682

  • 1. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.
    Kerns WD, Arena E, Macia RA, Bugelski PJ, Matthews WD, Morgan DG.
    Toxicol Pathol; 1989; 17(1 Pt 2):203-13. PubMed ID: 2568682
    [Abstract] [Full Text] [Related]

  • 2. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
    Kerns WD, Arena E, Morgan DG.
    Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297
    [Abstract] [Full Text] [Related]

  • 3. Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator.
    Yuhas EM, Morgan DG, Arena E, Kupp RP, Saunders LZ, Lewis HB.
    Am J Pathol; 1985 Apr; 119(1):83-91. PubMed ID: 2858975
    [Abstract] [Full Text] [Related]

  • 4. Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilator.
    Bugelski PJ, Vockley CM, Sowinski JM, Arena E, Berkowitz BA, Morgan DG.
    Br J Exp Pathol; 1989 Apr; 70(2):153-65. PubMed ID: 2567179
    [Abstract] [Full Text] [Related]

  • 5. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA, Sabouni MH, Ansari AF, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [Abstract] [Full Text] [Related]

  • 6. IP66 (1[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine) enhances beta-adrenoceptor-induced vasodilatation in rat mesenteric vascular bed.
    Perretti F, Nediani C, Manzini S.
    Arch Int Pharmacodyn Ther; 1990 Aug; 306():87-99. PubMed ID: 1963768
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
    Hieble JP, Owen DA, Harvey CA, Blumberg AL, Valocik RE, DeMarinis RM.
    Clin Exp Hypertens A; 1987 Aug; 9(5-6):889-912. PubMed ID: 2887313
    [Abstract] [Full Text] [Related]

  • 8. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG, Lefebvre RA, Vanderniepen P.
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.
    Berkowitz BA, Ohlstein EH.
    J Cardiovasc Pharmacol; 1984 Jul; 6 Suppl 4():S559-63. PubMed ID: 6210423
    [Abstract] [Full Text] [Related]

  • 10. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD, Glock D, Goldberg LI.
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the arteritis induced by infusion of rats with UK-61,260, an inodilator, for 24 h. A comparison with the arteritis induced by fenoldopam mesylate.
    Hanton G, Le Net JL, Ruty B, Leblanc B.
    Arch Toxicol; 1995 Jan; 69(10):698-704. PubMed ID: 8572928
    [Abstract] [Full Text] [Related]

  • 12. The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.
    Ohlstein EH, Zabko-Potapovich B, Berkowitz BA.
    Eur J Pharmacol; 1985 Dec 03; 118(3):321-9. PubMed ID: 2867915
    [Abstract] [Full Text] [Related]

  • 13. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ, Barrett RJ, Adamski SW, Lokhandwala MF.
    J Pharmacol Exp Ther; 1984 Jun 03; 229(3):756-62. PubMed ID: 6144791
    [Abstract] [Full Text] [Related]

  • 14. Alpha-adrenoceptor blocking activity of fenoldopam (SK&F 82526), a selective DA1 agonist.
    Nakamura S, Kohli JD, Rajfer SI.
    J Pharm Pharmacol; 1986 Feb 03; 38(2):113-7. PubMed ID: 2870153
    [Abstract] [Full Text] [Related]

  • 15. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A, Moreau R, Bacq Y, Gaudin C, Braillon A, Lebrec D.
    Hepatology; 1991 Jan 03; 13(1):111-6. PubMed ID: 1671029
    [Abstract] [Full Text] [Related]

  • 16. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
    Polak MJ, Knight ME, Gause GE, Bucciarelli RL, Drummond W.
    J Appl Physiol (1985); 1989 Sep 03; 67(3):1076-80. PubMed ID: 2571605
    [Abstract] [Full Text] [Related]

  • 17. Bulbocapnine is not a selective DA1 receptor antagonist.
    Kohli JD, Glock D, Goldberg LI.
    J Pharm Pharmacol; 1986 May 03; 38(5):401-2. PubMed ID: 2872323
    [Abstract] [Full Text] [Related]

  • 18. Effects of SK&F 82526 and SK&F 83742 on the renal vascular dopamine receptor.
    Schmidt M, Imbs JL, Giesen-Crouse EM, Schwartz J.
    J Pharmacol; 1985 May 03; 16(1):15-22. PubMed ID: 2582206
    [Abstract] [Full Text] [Related]

  • 19. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.
    Schmidt M, Krieger JP, Giesen-Crouse EM, Imbs JL.
    Arch Int Pharmacodyn Ther; 1987 Apr 03; 286(2):195-205. PubMed ID: 2954515
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ, Smith JM, Shebuski RJ, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Aug 03; 242(2):573-8. PubMed ID: 2886644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.